Product Images Alendronate Sodium
View Photos of Packaging, Labels & Appearance
- chemical structure - alendronate sodium 70mg tab 4 pck for teva 1
- IMAGE LABEL - alendronate sodium 70mg tab 4 pck for teva 10
- figure 1 - alendronate sodium 70mg tab 4 pck for teva 2
- figure 2 - alendronate sodium 70mg tab 4 pck for teva 3
- figure 3 - alendronate sodium 70mg tab 4 pck for teva 4
- figure 3a - alendronate sodium 70mg tab 4 pck for teva 5
- figure 4 - alendronate sodium 70mg tab 4 pck for teva 6
- figure 4a - alendronate sodium 70mg tab 4 pck for teva 7
- figure 5 - alendronate sodium 70mg tab 4 pck for teva 8
- figure 6 - alendronate sodium 70mg tab 4 pck for teva 9
Product Label Images
The following 10 images provide visual information about the product associated with Alendronate Sodium NDC 33261-554 by Aidarex Pharmaceuticals Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
chemical structure - alendronate sodium 70mg tab 4 pck for teva 1
IMAGE LABEL - alendronate sodium 70mg tab 4 pck for teva 10
AIDAREX PHARMACEUTICALS LLC produces a medication called ALENDRONATE, available as a 70mg oral tablet. The medication is in three blister packs. The manufacturer's address is in Sellersville, PA, and their contact number is not available in the given text.*
figure 1 - alendronate sodium 70mg tab 4 pck for teva 2
Not available.*
figure 2 - alendronate sodium 70mg tab 4 pck for teva 3
figure 3 - alendronate sodium 70mg tab 4 pck for teva 4
This is a graph showing a study on Alendronate Sodium 10mg over a period of 36 months. The X-axis shows time in months and the Y-axis shows the effects of the drug. However, without additional context or data, it is difficult to provide further information or insights about the study.*
figure 3a - alendronate sodium 70mg tab 4 pck for teva 5
This is not-available as the text is incomplete and does not provide enough information to generate a useful description.*
figure 4 - alendronate sodium 70mg tab 4 pck for teva 6
This appears to be a table showing the change in BMD (bone mineral density) over a 2-year study for two different treatments - one with alendronate sodium (at a dosage of 5mg per day) and one with a placebo. The table shows the change in BMD at various locations in the body, including the femoral neck, trochanter, and total body.*
figure 4a - alendronate sodium 70mg tab 4 pck for teva 7
figure 5 - alendronate sodium 70mg tab 4 pck for teva 8
This appears to be a table or graph of information related to bone mineral density (BMD) changes from baseline in a 2-year study, with one group receiving alendronate Sodium 5 mg/day and the other receiving placebo. The BMD was measured in different parts of the body including the femoral neck and trochanter. However, without more context or clearer text, it is difficult to provide a more specific or useful description.*
figure 6 - alendronate sodium 70mg tab 4 pck for teva 9
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
